Home / About / What We Do / UHNWI direct
UHNWI direct
UHNWI direct is a premier service facilitating the transmission of information to the world's wealthiest and most influential individuals through our advanced routing platform. Our Wealth Intelligence Team conducts comprehensive data analysis to identify contact information for Ultra High Net Worth Individuals (UHNWIs). To safeguard personal data, we do not disclose this information; instead, we employ a secure and efficient messaging routing structure. Learn more about how it works.
To find the person you want to contact, start typing their name or other relevant keywords in the search bar.
Please note: Our database contains over 10,000 direct contacts of UHNWIs, and it is highly likely that the individual you are seeking is already included. However, creating individual profiles for each contact is a meticulous and time-intensive process, So, if you are unable to find the profile of the individual you are looking for, please click here.
Filter by Net Worth: All | Billionaires | Centi-Millionaires | Multi-Millionaires
Filter by Location: All | USA | Canada | Europe | UK | Russia & CIS | Asia | MEIA | Australia | Latin America
Leonard Schleifer | $1B+
Leonard Schleifer, cofounder and CEO of Regeneron Pharmaceuticals, built one of the most successful biotech companies in the world by combining scientific rigor with long-term investment in research. A trained neurologist turned entrepreneur, he launched Regeneron in 1988 and steered it through decades of discovery to blockbuster drugs such as Eylea, Dupixent, and leading monoclonal antibody therapies. Under his leadership, Regeneron became known for its genetics platform, deep scientific culture, and partnerships that accelerated medical breakthroughs. Schleifer’s blend of clinical expertise, business discipline, and research focus has made him a defining figure in the modern biotechnology landscape.
Marc Coucke | $1B+
Marc Coucke, Belgian entrepreneur and investor, built his fortune as the cofounder of Omega Pharma, transforming a small over-the-counter medicine distributor into one of Europe’s largest consumer healthcare companies before selling it to Perrigo for billions. After the sale, Coucke diversified through his investment company Alychlo, acquiring and backing businesses across pharmaceuticals, hospitality, sports, real estate, and leisure—including theme parks, luxury resorts, and the Belgian football club R.S.C. Anderlecht. Known for his charismatic style, bold dealmaking, and expansive portfolio, Coucke has become one of Belgium’s most influential business figures, blending entrepreneurial drive with high-profile investments across Europe.
George Yancopoulos | $1B+
George Yancopoulos, cofounder, president, and chief scientific officer of Regeneron Pharmaceuticals, is one of the most accomplished scientist-executives in biotechnology. A Columbia-trained physician and molecular immunologist, he helped shape Regeneron’s R&D engine, leading to breakthrough therapies in ophthalmology, immunology, oncology, and infectious disease. Under his guidance, the company developed Eylea, a blockbuster treatment for macular degeneration, and partnered in creating COVID-19 antibody therapies. With hundreds of patents and a reputation for scientific rigor, Yancopoulos has become a driving force behind Regeneron’s rise as a global biotech leader.
Dilip Shanghvi | $10B+
Dilip Shanghvi is an Indian billionaire businessman, best known as the founder of Sun Pharmaceuticals, the largest pharmaceutical company in India and among the top generic drug makers in the world. His strategic vision and leadership have made significant impacts on the pharmaceutical industry globally.